B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
-4.61%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$2.42B
AUM Growth
-$122M
(-4.8%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
32.13%
Holding
794
New
116
Increased
220
Reduced
211
Closed
134
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$69.6M |
| 2 |
iShares National Muni Bond ETF
MUB
|
$48.6M |
| 3 |
iShares Short-Term National Muni Bond ETF
SUB
|
$30.6M |
| 4 |
iShares California Muni Bond ETF
CMF
|
$16.9M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
$11.6M |
Top Sells
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Healthcare | 8.88% |
| 3 | Financials | 6.63% |
| 4 | Consumer Discretionary | 4.47% |
| 5 | Industrials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
601
DELISTED
Veren
VRN
| $203K | 0.01% |
+33,000
| New | +$203K |
|
602
Capricor Therapeutics
CAPR
$308M
| $202K | 0.01% |
33,601
+3,800
| +13% | +$22.8K |
|
603
iShares Silver Trust
SLV
$20.1B
| $198K | 0.01% |
+11,297
| New | +$198K |
|
|
MFA
604
MFA Financial
MFA
$1.07B
| $197K | 0.01% |
25,300
-24,976
| -50% | -$194K |
|
605
Modine Manufacturing
MOD
$7.1B
| $196K | 0.01% |
+15,157
| New | +$196K |
|
606
Richardson Electronics
RELL
$141M
| $189K | 0.01% |
+12,500
| New | +$189K |
|
|
ARI
607
Apollo Commercial Real Estate
ARI
$1.53B
| $188K | 0.01% |
22,640
| – | – |
|
608
AT&T
T
$212B
| $187K | 0.01% |
12,162
+242
| +2% | +$3.72K |
|
609
Snap
SNAP
$12.4B
| $186K | 0.01% |
18,974
| – | – |
|
610
CareTrust REIT
CTRE
$7.56B
| $181K | 0.01% |
10,000
| – | – |
|
611
Annexon
ANNX
$238M
| $180K | 0.01% |
29,086
| – | – |
|
612
SLM Corp
SLM
$6.49B
| $175K | 0.01% |
+12,522
| New | +$175K |
|
|
KLRS
613
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $173K | 0.01% |
952
| – | – |
|
614
Utz Brands
UTZ
$1.19B
| $172K | 0.01% |
+11,400
| New | +$172K |
|
615
Macy's
M
$4.64B
| $171K | 0.01% |
+10,900
| New | +$171K |
|
616
Voyager Therapeutics
VYGR
$235M
| $171K | 0.01% |
+28,900
| New | +$171K |
|
617
89bio
ETNB
$1.32B
| $167K | 0.01% |
28,892
-800
| -3% | -$4.62K |
|
618
Kezar Life Sciences
KZR
$29.8M
| $164K | 0.01% |
+1,902
| New | +$164K |
|
619
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $151K | 0.01% |
33,994
+2,073
| +6% | +$9.21K |
|
|
PCTI
620
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $149K | 0.01% |
+31,547
| New | +$149K |
|
621
Ironwood Pharmaceuticals
IRWD
$188M
| $140K | 0.01% |
13,500
| – | – |
|
622
Viatris
VTRS
$12.2B
| $140K | 0.01% |
16,456
| – | – |
|
623
Puma Biotechnology
PBYI
$253M
| $127K | 0.01% |
53,500
| – | – |
|
624
ProPhase Labs
PRPH
$14.7M
| $126K | 0.01% |
+11,200
| New | +$126K |
|
625
Allogene Therapeutics
ALLO
$255M
| $125K | 0.01% |
+11,600
| New | +$125K |
|